Telo Genomics Corp (V:TELO) — Market Cap & Net Worth
Market Cap & Net Worth: Telo Genomics Corp (TELO)
Telo Genomics Corp (V:TELO) has a market capitalization of $3.63 Million (CA$5.02 Million) as of May 2, 2026. Listed on the V stock exchange, this Canada-based company holds position #28926 globally and #1370 in its home market, demonstrating a -9.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Telo Genomics Corp's stock price CA$0.05 by its total outstanding shares 100430472 (100.43 Million). Analyse how efficiently does Telo Genomics Corp generate cash to see how efficiently the company converts income to cash.
Telo Genomics Corp Market Cap History: 2015 to 2026
Telo Genomics Corp's market capitalization history from 2015 to 2026. Data shows change from $65.38 Million to $3.63 Million (-24.78% CAGR).
Telo Genomics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Telo Genomics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TELO by Market Capitalization
Companies near Telo Genomics Corp in the global market cap rankings as of May 2, 2026.
Key companies related to Telo Genomics Corp by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Telo Genomics Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Telo Genomics Corp's market cap moved from $65.38 Million to $ 3.63 Million, with a yearly change of -24.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$3.63 Million | 0.00% |
| 2025 | CA$3.63 Million | -61.54% |
| 2024 | CA$9.44 Million | -35.00% |
| 2023 | CA$14.53 Million | -43.66% |
| 2022 | CA$25.79 Million | -17.44% |
| 2021 | CA$31.24 Million | +59.26% |
| 2020 | CA$19.62 Million | +50.00% |
| 2019 | CA$13.08 Million | +2.86% |
| 2018 | CA$12.71 Million | -87.04% |
| 2017 | CA$98.08 Million | -70.33% |
| 2016 | CA$330.56 Million | +405.56% |
| 2015 | CA$65.38 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Telo Genomics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.63 Million USD |
| MoneyControl | $3.63 Million USD |
| MarketWatch | $3.63 Million USD |
| marketcap.company | $3.63 Million USD |
| Reuters | $3.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Telo Genomics Corp
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive o… Read more